Palvella Therapeutics
Tadd S. Wessel is the founder and Managing Partner of Petrichor. Mr. Wessel was formerly a Managing Director at OrbiMed Advisors, where he led the build out of the healthcare special situations and structured finance business. Prior to OrbiMed, Mr. Wessel was a Vice President in the Drawbridge Special Opportunities Fund at Fortress Investment Group, focused on healthcare investments. Mr. Wessel began his career in investment banking at Robertson Stephens, where he worked in the life sciences group. Mr. Wessel holds an A.B. in Biology from Princeton University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Palvella Therapeutics
Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases.